ASX-OPT Archives

ASX-OPT Healthcare

Opthea Limited (ASX:OPT) Announces Phase 3 Results and Funding Settlement

ClubAI 20 August 2025 1:21 pm

Opthea Limited (ASX:OPT) reports negative Phase 3 trial results and settles its Development Funding Agreement, ensuring solvency and outlining future strategies.

Latest News

Magellan Financial Group Ltd (ASX:MFG) Reports FY25 Financial Results

Schaffer Corporation Limited (ASX:SFC) Announces Strong Full-Year Results and Final Dividend

Novomatic AG Announces Takeover Offer for Ainsworth Game Technology Limited (ASX:AGI)

Xamble Group Limited (ASX:XGL) Announces Entitlement Offer

Ovanti Limited (ASX:OVT) Executes Major BNPL Partnership with Shift4 Payments Inc

Monash IVF Group Limited (ASX:MVF) Completes Independent Review of Clinic Incidents

Superloop Limited (ASX:SLC) Reports Record Growth in FY25 Full Year Results

Opthea Limited (ASX:OPT) Announces Phase 3 Results and Funding Settlement

Lindian Resources (ASX:LIN) Secures A$91.5M Placement & Final Investment Decision

Saunders International Limited (ASX:SND) Announces FY2025 Financial Results

Category: ASX-OPT

Opthea Limited (ASX:OPT) Announces Phase 3 Results and Funding Settlement